Revance Therapeutics, Inc.


Revance Therapeutics, Inc. Website Screenshot

http://www.revance.com

Revance Therapeutics, Inc. Company Intro

By selecting "I accept," I authorize Revance, or any contracted third parties acting on its behalf, to install cookies on my browser. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media.

Industry

Healthcare

Revance Therapeutics, Inc. Headquaters

7555 Gateway Boulevard
Newark,94560
United States


Revance Therapeutics, Inc. Share price

14 Sep 2022 10:10 GMT

$25.40

-2.69 (-9.58 %)


Revance Therapeutics, Inc. Market cap

$1.933 B


WMC RANKING

2022

Revance Therapeutics, Inc. # 285

Biotechnology

Latest Revance Therapeutics, Inc. News

News 09 Dec 2022

There's a different equity story being told by sentiment ...

As of close of business last night, Revance Therapeutics Inc.'s stock clocked out at $22.08, up 3.32% from its previous closing price of $21.37.

News 08 Dec 2022

Is that what Sustainable Earning stands for?: Revance ...

In a post published today on Yahoo Finance, Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic...

News 08 Dec 2022

Is that what Sustainable Earning stands for?: Revance ...

In a post published today on Yahoo Finance, Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic...


WMC Market Score


WMC Market to Revenue Score


Revance Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Revance Therapeutics, Inc. USD $28,566 $301,794 $-291,795 $19,330B 285
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $754,300B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $713,610B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,520B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Revance Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Revance Therapeutics, Inc. Post vs Top 4 Industry Competitors




Revance Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Revance Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Revance Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Revance Therapeutics, Inc. 0.31 0.49 0.09 0 0 0 0.26
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries